Alimera Sciences, Inc. to Present at the H.C. Wainwright 23rd Annual Global Investment Virtual Conference
Alimera Sciences (Nasdaq: ALIM) announces that CEO Rick Eiswirth will present at the 23rd Annual H.C.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Alimera Sciences (Nasdaq: ALIM) announces that CEO Rick Eiswirth will present at the 23rd Annual H.C. Wainwright Global Investment Conference from September 13-15, 2021. The corporate presentation will be available on September 13 at 7:00 AM ET. Additionally, David Holland, Chief Marketing Officer, and Philip Ashman, Chief Operating Officer, will be available for one-on-one meetings throughout the event. Interested investors can register to attend the conference via the provided link.
Details
News Market Reaction – ALIM
The recorded move for ALIM in the trading session of this news was +3.44%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
ATLANTA, Sept. 02, 2021 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (Nasdaq: ALIM) (“Alimera”), Alimera Sciences, Inc. (Nasdaq: ALIM) (“Alimera”), a global pharmaceutical company whose mission is to be invaluable to patients, physicians and partners concerned with retinal health and maintaining better vision longer., announces today that Chief Executive Officer Rick Eiswirth will present at the 23rd Annual H.C. Wainwright Global Investment Conference which is being held virtually from September 13 – 15, 2021.
Mr. Eiswirth will deliver his corporate presentation, which will become available beginning on September 13 at 7:00 AM ET.
David Holland, Chief Marketing Officer and Philip Ashman, Chief Operating Officer will be available for one-on-one meetings throughout the conference.
Investors can register here: www.hcwevents.com.
About Alimera Sciences, Inc.
Alimera Sciences a global pharmaceutical company whose mission is to be invaluable to patients, physicians and partners concerned with retinal health and maintaining better vision longer. For more information, please visit www.alimerasciences.com.
| For press inquiries: | For investor inquiries: |
| Jules Abraham | Scott Gordon |
| for Alimera Sciences | for Alimera Sciences |
| 917-885-7378 | scottg@coreir.com |
| julesa@coreir.com |
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.